StockData
Greenwich LifeSciences, Inc. logo

Greenwich LifeSciences, Inc. (GLSI) stock

GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 6/30
$18.70+4.94 (+35.90%)

Close on Nov 17, 2026Market cap $274.48MP/E –Yield –

Greenwich LifeSciences cash

Cash and short-term investments held at the end of each period.

Greenwich LifeSciences's cash was $8.88M at Jun 30, 2026. For fiscal 2025 it was $6.18M, up 51.0% from the year before. The highest annual figure on record is $28.66M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.18M+51.0%
FY2024Dec 31, 2024$4.09M-41.5%
FY2023Dec 31, 2023$6.99M-48.1%
FY2022Dec 31, 2022$13.47M-50.5%
FY2021Dec 31, 2021$27.20M-5.1%
FY2020Dec 31, 2020$28.66M+419217.8%
FY2019Dec 31, 2019$6.84K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.88M+184.0%
Q1 FY2026Mar 31, 2026$10.51M+282.0%
Q4 FY2025Dec 31, 2025$6.18M+51.0%
Q3 FY2025Sep 30, 2025$3.81M-34.6%
Q2 FY2025Jun 30, 2025$3.13M-56.7%
Q1 FY2025Mar 31, 2025$2.75M-50.1%
Q4 FY2024Dec 31, 2024$4.09M-41.5%
Q3 FY2024Sep 30, 2024$5.82M-36.3%
Q2 FY2024Jun 30, 2024$7.22M-34.0%
Q1 FY2024Mar 31, 2024$5.51M-53.8%
Q4 FY2023Dec 31, 2023$6.99M-48.1%
Q3 FY2023Sep 30, 2023$9.14M-41.5%
Q2 FY2023Jun 30, 2023$10.94M-36.3%
Q1 FY2023Mar 31, 2023$11.91M-39.7%
Q4 FY2022Dec 31, 2022$13.47M-50.5%
Q3 FY2022Sep 30, 2022$15.64M-45.9%
Q2 FY2022Jun 30, 2022$17.19M-42.3%
Q1 FY2022Mar 31, 2022$19.74M-35.1%
Q4 FY2021Dec 31, 2021$27.20M-5.1%
Q3 FY2021Sep 30, 2021$28.91M+365.2%
Q2 FY2021Jun 30, 2021$29.80M+435900.5%
Q1 FY2021Mar 31, 2021$30.40M–
Q4 FY2020Dec 31, 2020$28.66M–
Q3 FY2020Sep 30, 2020$6.21M–
Q4 FY2019Dec 31, 2019$6.84K–

More Greenwich LifeSciences figures

See a number that looks wrong?